Lu T - Search Results

1

Elevated plasma fibrinogen level shows superior prognostic value than Epstein-Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.

Lan M, Chen C, Huang Y, Mao M, Han F, Liao J, Deng M, Duan Z, Zheng L, Wu S, Lu T, Jian Y. Lan M, et al. Among authors: lu t. Oncotarget. 2016 Jul 19;7(29):46242-46252. doi: 10.18632/oncotarget.10083. Oncotarget. 2016. PMID: 27323828 Free PMC article.

2

Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.

Sun X, Su S, Chen C, Han F, Zhao C, Xiao W, Deng X, Huang S, Lin C, Lu T. Sun X, et al. Among authors: lu t. Radiother Oncol. 2014 Mar;110(3):398-403. doi: 10.1016/j.radonc.2013.10.020. Epub 2013 Nov 11. Radiother Oncol. 2014. PMID: 24231245

3

[Concurrent chemotherapy with different dose regimens of cisplatin for nasopharyngeal carcinoma using intensity-modulated radiation therapy: a phase II prospective randomized controlled trial].

Liu S, Han F, Chen C, Zeng L, Sun X, Lu T. Liu S, et al. Among authors: lu t. Zhonghua Zhong Liu Za Zhi. 2014 Oct;36(10):778-82. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25567311 Clinical Trial. Chinese.

4

The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma.

Guan Y, Li A, Xiao W, Liu S, Chen B, Lu T, Zhao C, Han F. Guan Y, et al. Among authors: lu t. Oncotarget. 2015 Oct 20;6(32):33926-34. doi: 10.18632/oncotarget.5271. Oncotarget. 2015. PMID: 26418895 Free PMC article.

5

Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Lu L, Li J, Zhao C, Xue W, Han F, Tao T, Chang H, Jia W, Lu T. Lu L, et al. Among authors: lu t. Oral Oncol. 2016 Sep;60:18-24. doi: 10.1016/j.oraloncology.2016.06.013. Epub 2016 Jun 30. Oral Oncol. 2016. PMID: 27531868

6

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis.

Lan M, Chen C, Huang Y, Tian L, Duan Z, Han F, Liao J, Deng M, Sio TT, Prayongrat A, Zheng L, Wu S, Lu T. Lan M, et al. Among authors: lu t. Sci Rep. 2017 Feb 17;7:42624. doi: 10.1038/srep42624. Sci Rep. 2017. PMID: 28211482 Free PMC article.

7

Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.

Sun X, Zeng L, Chen C, Huang Y, Han F, Xiao W, Liu S, Lu T. Sun X, et al. Among authors: lu t. Radiat Oncol. 2013 Nov 13;8:265. doi: 10.1186/1748-717X-8-265. Radiat Oncol. 2013. PMID: 24219818 Free PMC article.

8

[Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial].

Chen CY, Lu TX, Zhao C, Lu LX, Han F, Sun Y. Chen CY, et al. Ai Zheng. 2007 Apr;26(4):398-402. Ai Zheng. 2007. PMID: 17430660 Free article. Clinical Trial. Chinese.

9

Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma.

Xiao WW, Han F, Lu TX, Chen CY, Huang Y, Zhao C. Xiao WW, et al. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1070-6. doi: 10.1016/j.ijrobp.2008.09.008. Epub 2009 Feb 21. Int J Radiat Oncol Biol Phys. 2009. PMID: 19231110

10

[Clinical features of 337 patients with recurrent nasopharyngeal carcinoma].

Li JX, Lu TX, Huang Y, Han F, Chen CY, Xiao WW. Li JX, et al. Chin J Cancer. 2010 Jan;29(1):82-6. doi: 10.5732/cjc.009.10412. Chin J Cancer. 2010. PMID: 20038316 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,806 results

Search Page

Filters